X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
humans (12) 12
oncology (11) 11
female (10) 10
aged (8) 8
middle aged (8) 8
adult (7) 7
male (7) 7
cetuximab (5) 5
colorectal neoplasms - drug therapy (5) 5
disease-free survival (5) 5
mutation (5) 5
aged, 80 and over (4) 4
antibodies, monoclonal, humanized (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
colorectal neoplasms - genetics (4) 4
melanoma (4) 4
treatment outcome (4) 4
antibodies, monoclonal - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
cancer (3) 3
care and treatment (3) 3
colorectal neoplasms - pathology (3) 3
dose-response relationship, drug (3) 3
efficacy (3) 3
immunohistochemistry (3) 3
kras (3) 3
maximum tolerated dose (3) 3
neoplasm metastasis (3) 3
research (3) 3
therapy (3) 3
tumors (3) 3
analysis (2) 2
antibodies, monoclonal - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
breast neoplasms - drug therapy (2) 2
breast neoplasms - metabolism (2) 2
breast neoplasms - pathology (2) 2
camptothecin - analogs & derivatives (2) 2
camptothecin - therapeutic use (2) 2
colon-cancer (2) 2
colorectal cancer (2) 2
colorectal neoplasms - mortality (2) 2
combination (2) 2
development and progression (2) 2
diagnosis (2) 2
drug administration schedule (2) 2
esophageal cancer (2) 2
expression (2) 2
gastroenterology & hepatology (2) 2
gene expression (2) 2
gene mutations (2) 2
genetic testing (2) 2
genetics (2) 2
health aspects (2) 2
hematology, oncology and palliative medicine (2) 2
k-ras mutations (2) 2
metastasis (2) 2
microsatellite instability (2) 2
multicenter (2) 2
multivariate analysis (2) 2
mutation - genetics (2) 2
neoplasm staging (2) 2
nras (2) 2
organoplatinum compounds - administration & dosage (2) 2
organoplatinum compounds - adverse effects (2) 2
patients (2) 2
phenotype (2) 2
predictive biomarkers (2) 2
prognosis (2) 2
proteins (2) 2
proto-oncogene proteins - genetics (2) 2
proto-oncogene proteins b-raf - genetics (2) 2
proto-oncogene proteins p21 (2) 2
ras proteins - genetics (2) 2
receptors, estrogen - metabolism (2) 2
squamous cell carcinoma (2) 2
1st-line treatment (1) 1
acid (1) 1
activation (1) 1
adam proteins - biosynthesis (1) 1
adam9 (1) 1
adhesion (1) 1
advanced melanoma (1) 1
american-society (1) 1
aminopyridines - administration & dosage (1) 1
aminopyridines - adverse effects (1) 1
animals (1) 1
anti-egfr treatment (1) 1
antibodies, monoclonal (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibody (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic agents, immunological - administration & dosage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2009, Volume 27, Issue 5, pp. 663 - 671
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2013, Volume 31, Issue 20, pp. 2586 - 2592
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 14, pp. 2311 - 2319
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 09/2017, Volume 17, Issue 1, pp. 646 - 646
Journal Article
The Lancet Haematology, ISSN 2352-3026, 08/2017, Volume 4, Issue 8, pp. e350 - e361
GP2013 is a rituximab biosimilar developed to stringent development guidelines, including non-clinical and preclinical investigations and clinical trials in... 
MAINTENANCE | PREDNISONE | THERAPY | RESPONSE CRITERIA | ONCOLOGY | CYCLOPHOSPHAMIDE | CLINICAL-TRIALS | VINCRISTINE | CVP | HEMATOLOGY | GP2013 | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. 936 - 936
Journal Article
Oncotarget, ISSN 1949-2553, 03/2019, Volume 10, Issue 19, pp. 1850 - 1859
and are the most frequently mutated mitogen-activated protein kinase (MAPK) genes in melanoma. Binimetinib is a highly selective MAPK kinase (MEK) 1/2... 
Journal Article
Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. 2437 - 2437
Journal Article
BMC Cancer, ISSN 1471-2407, 07/2016, Volume 16, Issue 1
Primary melanocytic neoplasms are rare in the pediatric age. Among them, the pattern of neoplastic meningitis represents a peculiar diagnostic challenge since... 
mutation | NRAS | NRAS inhibitors | Primary leptomeningeal melanoma | Children | Tuberculous meningitis | Melanoma | Physiological aspects | Antitubercular agents | Research | Diagnosis | Cerebrospinal fluid | Health aspects
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 05/2012, Volume 10, Issue 1, pp. 87 - 87
Journal Article
Journal Article